Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Soligenix (SNGX) EBT (2016 - 2025)

Soligenix (SNGX) has disclosed EBT for 16 consecutive years, with -$2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 47.04% year-over-year to -$2.5 million, compared with a TTM value of -$11.9 million through Sep 2025, down 53.85%, and an annual FY2024 reading of -$8.7 million, down 9.7% over the prior year.
  • EBT was -$2.5 million for Q3 2025 at Soligenix, up from -$2.7 million in the prior quarter.
  • Across five years, EBT topped out at -$1.6 million in Q2 2023 and bottomed at -$4.7 million in Q4 2021.
  • Average EBT over 5 years is -$2.8 million, with a median of -$2.7 million recorded in 2025.
  • Peak annual rise in EBT hit 71.94% in 2021, while the deepest fall reached 100.4% in 2021.
  • Year by year, EBT stood at -$4.7 million in 2021, then grew by 20.2% to -$3.8 million in 2022, then surged by 35.35% to -$2.4 million in 2023, then plummeted by 39.97% to -$3.4 million in 2024, then increased by 25.57% to -$2.5 million in 2025.
  • Business Quant data shows EBT for SNGX at -$2.5 million in Q3 2025, -$2.7 million in Q2 2025, and -$3.2 million in Q1 2025.